/compare — side-by-sideLOADING
Valuation, growth, margins and forensic scores side-by-side — computed from each company's own SEC filings and last EOD close. No estimates, no fluff.
| Metric | SVASINOVAC BIOTECH LTD |
|---|---|
| Last close | — |
| Change % | — |
| Market cap | — |
| P/E | — |
| Revenue | $386M |
| Rev growth (YoY) | 6.8% |
| Net income | $-198836000 |
| Net margin | -51.5% |
| EPS (diluted) | $-0.83 |
| Piotroski F-Score | 3 |
| Altman Z-Score | — |
| Beneish M-Score | -2.41 |
| Next earnings | — |
Fundamentals from XBRL company facts (as filed); market cap & P/E use last EOD close. Green = best in the row among the compared names. Educational only — not investment advice.